Stock listing
BIVA:SRPT Sarepta Therapeutics, Inc. Acciones
Mexican listing (BIVA) of Sarepta Therapeutics, Inc. · home listing NASDAQ:SRPT
Follow Sarepta Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:SRPT
$17.73 USD +0.63 (+3.7%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SRPT
- Day range
- $17.12 – $17.83 USDOct 19, 2026
- Volume
- 2.33M sharesOct 19, 2026
- Market cap
- $1.87B USDAt the close on Oct 19, 2026 · price × 105.6M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SRPT · Home | $17.73 USD | +0.63 (+3.7%) | 2,326,843 | $17.25 | $17.83 | $17.12 | $17.10 | Close on Oct 19, 2026 |
| B3:S1RP34 | 4.33 BRL | -0.02 (-0.5%) | 11 | 4.33 | 4.33 | 4.33 | 4.35 | Close on Oct 19, 2026 |
| LSE:0L35 | $17.73 USD | +0.235 (+1.3%) | 688 | $17.10 | $17.74 | $17.00 | $17.50 | Close on Oct 19, 2026 |
| Frankfurt:AB3A | €15.10 EUR | -0.60 (-3.8%) | — | €15.10 | €15.10 | €15.10 | €15.70 | Close on Oct 19, 2026 |
| Munich:AB3A | €15.30 EUR | -0.58 (-3.7%) | — | €15.30 | €15.30 | €15.30 | €15.88 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:SRPT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $17.73 | +0.63 | +3.7% | $17.25 | $17.83 | $17.12 | 2,326,843 | |
| $17.10 | -0.69 | -3.9% | $17.82 | $17.84 | $16.88 | 9,855,870 | |
| $17.79 | +0.96 | +5.7% | $16.89 | $17.95 | $16.61 | 4,041,189 | |
| $16.83 | +0.32 | +1.9% | $16.53 | $16.91 | $16.37 | 2,740,100 | |
| $16.51 | -0.93 | -5.3% | $17.12 | $17.23 | $16.41 | 3,683,017 | |
| $17.44 | -0.41 | -2.3% | $17.88 | $18.14 | $17.30 | 3,282,802 | |
| $17.85 | -0.36 | -2.0% | $18.25 | $18.53 | $17.68 | 3,015,056 | |
| $18.21 | +0.71 | +4.1% | $17.28 | $18.28 | $17.20 | 3,515,399 | |
| $17.50 | +0.19 | +1.1% | $17.28 | $17.67 | $16.98 | 2,872,800 | |
| $17.31 | -0.18 | -1.0% | $17.60 | $17.65 | $17.04 | 2,690,400 | |
| $17.49 | -0.01 | -0.1% | $17.39 | $17.55 | $17.10 | 2,198,100 | |
| $17.50 | -0.07 | -0.4% | $17.75 | $17.76 | $17.21 | 2,549,700 | |
| $17.57 | -0.65 | -3.6% | $18.14 | $18.25 | $17.52 | 2,884,300 | |
| $18.22 | -0.42 | -2.3% | $18.64 | $18.69 | $18.06 | 1,995,000 | |
| $18.64 | -0.16 | -0.9% | $18.68 | $18.74 | $18.38 | 1,368,600 | |
| $18.80 | +0.13 | +0.7% | $18.43 | $18.86 | $17.64 | 2,266,200 | |
| $18.67 | +0.28 | +1.5% | $18.49 | $18.77 | $18.02 | 2,218,600 | |
| $18.39 | -0.56 | -3.0% | $18.85 | $19.14 | $18.05 | 2,561,800 | |
| $18.95 | -1.86 | -8.9% | $20.72 | $20.76 | $18.74 | 3,757,100 | |
| $20.81 | +0.67 | +3.3% | $20.46 | $21.19 | $20.19 | 2,192,600 | |
| $20.14 | +0.03 | +0.1% | $20.29 | $20.50 | $19.97 | 1,756,500 | |
| $20.11 | -0.56 | -2.7% | $20.63 | $20.74 | $19.62 | 6,292,300 | |
| $20.67 | +0.91 | +4.6% | $20.23 | $21.75 | $19.97 | 2,588,000 | |
| $19.76 | -0.96 | -4.6% | $20.68 | $20.89 | $19.72 | 2,509,400 | |
| $20.72 | -0.20 | -1.0% | $20.81 | $21.06 | $20.29 | 2,534,700 | |
| $20.92 | +0.47 | +2.3% | $20.55 | $21.40 | $20.38 | 2,192,900 | |
| $20.45 | -0.07 | -0.3% | $20.76 | $21.10 | $20.29 | 1,810,700 | |
| $20.52 | -1.50 | -6.8% | $22.02 | $22.02 | $20.28 | 2,204,000 | |
| $22.02 | +1.08 | +5.2% | $20.81 | $23.22 | $20.63 | 4,164,800 | |
| $20.94 | -1.56 | -6.9% | $19.86 | $21.32 | $19.51 | 6,241,900 | |
| $22.50 | -0.49 | -2.1% | $22.58 | $22.65 | $21.98 | 2,955,500 | |
| $22.99 | -0.22 | -0.9% | $23.15 | $23.34 | $22.42 | 2,768,100 | |
| $23.21 | +1.88 | +8.8% | $21.33 | $23.62 | $21.33 | 4,806,600 | |
| $21.33 | +0.30 | +1.4% | $20.88 | $21.82 | $20.55 | 2,623,500 | |
| $21.03 | +0.17 | +0.8% | $20.56 | $21.16 | $20.18 | 2,656,600 | |
| $20.86 | -0.73 | -3.4% | $21.49 | $22.58 | $20.83 | 3,612,200 | |
| $21.59 | +2.13 | +10.9% | $19.35 | $22.59 | $18.77 | 7,918,700 | |
| $19.46 | +0.54 | +2.9% | $18.74 | $19.48 | $18.31 | 2,409,600 | |
| $18.92 | +0.79 | +4.4% | $18.42 | $19.05 | $18.19 | 1,696,200 | |
| $18.13 | -0.66 | -3.5% | $18.53 | $18.71 | $17.90 | 1,380,900 | |
| $18.79 | -0.43 | -2.2% | $19.39 | $19.73 | $18.66 | 1,674,600 | |
| $19.22 | -0.51 | -2.6% | $19.42 | $19.95 | $18.59 | 2,913,400 | |
| $19.73 | +1.71 | +9.5% | $18.74 | $20.19 | $18.74 | 4,943,300 | |
| $18.02 | -0.16 | -0.9% | $18.17 | $18.29 | $17.88 | 1,600,200 | |
| $18.18 | +0.08 | +0.4% | $17.93 | $18.30 | $17.72 | 1,728,600 | |
| $18.10 | -0.32 | -1.7% | $18.22 | $18.26 | $17.69 | 1,561,000 | |
| $18.42 | +0.04 | +0.2% | $18.41 | $18.73 | $18.20 | 2,518,300 | |
| $18.38 | +0.16 | +0.9% | $18.06 | $18.49 | $17.86 | 2,369,300 | |
| $18.22 | +1.04 | +6.1% | $17.23 | $18.25 | $17.23 | 3,002,800 | |
| $17.18 | +0.40 | +2.4% | $16.53 | $17.21 | $16.38 | 2,696,500 | |
| $16.78 | 0.00 | 0.0% | $16.87 | $17.26 | $16.47 | 3,064,000 | |
| $16.78 | +0.85 | +5.3% | $16.66 | $17.19 | $16.35 | 5,241,200 | |
| $15.93 | -0.46 | -2.8% | $16.43 | $16.76 | $15.82 | 3,109,300 | |
| $16.39 | +0.51 | +3.2% | $16.01 | $16.45 | $15.64 | 2,878,700 | |
| $15.88 | +1.02 | +6.9% | $15.09 | $15.89 | $14.75 | 3,799,700 | |
| $14.86 | -0.70 | -4.5% | $15.50 | $15.65 | $14.84 | 3,603,400 | |
| $15.56 | +0.02 | +0.1% | $15.54 | $15.65 | $15.04 | 3,022,000 | |
| $15.54 | +0.11 | +0.7% | $15.43 | $15.86 | $15.09 | 2,858,300 | |
| $15.43 | -0.46 | -2.9% | $15.74 | $15.98 | $15.05 | 3,523,600 | |
| $15.89 | +0.21 | +1.3% | $16.46 | $16.69 | $15.88 | 3,699,600 | |
| $15.68 | -0.20 | -1.3% | $15.88 | $16.03 | $15.49 | 2,141,900 | |
| $15.88 | +0.06 | +0.4% | $15.57 | $16.02 | $15.43 | 2,485,500 | |
| $15.82 | -0.39 | -2.4% | $16.20 | $16.37 | $15.81 | 2,426,900 | |
| $16.21 | -0.62 | -3.7% | $16.81 | $17.22 | $16.02 | 4,123,300 | |
| $16.83 | -0.39 | -2.3% | $17.39 | $17.70 | $16.83 | 1,777,100 |
- Ticker
- BIVA:SRPT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BIVA
- Currency
- MXN
What changed lately
Latest news release · Oct 14, 2026
Sarepta Therapeutics Presents New Preclinical Data Demonstrating Robust Knockdown of Pathogenic DMPK RNA in the Nucleus with SRP-1003 in DM1 at 2026 Oligonucleotide Therapeutics Society Annual Meeting
Latest earnings call · Aug 5, 2026
Sarepta Therapeutics (NASDAQ:SRPT) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 5, 2026
Q2 2026 Earnings Presentation
Earnings · 31 slides
Calls
Replays
Sarepta Therapeutics (NASDAQ:SRPT) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 5:30 PM ET
Watch TranscriptSarepta Therapeutics (NASDAQ:SRPT) Q1 2026 Earnings Call
Wed, May 06, 2026 · 4:30 PM ET
Watch TranscriptSarepta Therapeutics (NASDAQ:SRPT) Q4 2025 Earnings Call
Wed, Feb 25, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Sarepta Therapeutics Presents New Preclinical Data Demonstrating Robust Knockdown of Pathogenic DMPK RNA in the Nucleus with SRP-1003 in DM1 at 2026 Oligonucleotide Therapeutics Society Annual Meeting
Oct 14, 2026
Closed $16.83 (+1.9%) on Oct 14, 2026
Sarepta Therapeutics Presents New Data at 2026 World Muscle Society Annual Congress Demonstrating Safety and Clinically Meaningful Functional Benefit of ELEVIDYS (delandistrogene moxeparvovec) in Older Ambulatory Patients with Duchenne
Sep 30, 2026
Closed $18.22 (-2.3%) on Sep 30, 2026
Sarepta Therapeutics Announces Presentations at 2026 World Muscle Society Annual Congress
Sep 25, 2026
Closed $18.67 (+1.5%) on Sep 25, 2026
Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 27th Annual Neuromuscular Study Group Scientific Meeting
Sep 24, 2026
Closed $18.39 (-3.0%) on Sep 24, 2026
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2026-2027 Academic Year
Sep 8, 2026
Closed $20.94 (-6.9%) on Sep 8, 2026
Sarepta Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Aug 31, 2026
Closed $21.33 (+1.4%) on Sep 1, 2026
Sarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments
Aug 5, 2026
Closed $16.78 (+5.3%) on Aug 6, 2026
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
Jul 30, 2026
Closed $15.56 (+0.1%) on Jul 30, 2026
Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer
Jul 27, 2026
Closed $15.89 (+1.3%) on Jul 27, 2026
Sarepta Therapeutics to Announce Second Quarter 2026 Financial Results
Jul 22, 2026
Closed $15.82 (-2.4%) on Jul 22, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 31 slides · Aug 5, 2026
Investor Presentation (August 2026)
Investor deck · 86 slides · August 2026
Q1 2026 Earnings Presentation
Earnings · 24 slides · May 6, 2026
Technical Presentation (March 2026)
Technical · 37 slides · Mar 25, 2026
Sarepta Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 40 in the last 12 months · 231 in all · newest Oct 14, 2026 · oldest 2019
- Calls
- 17 calls with a replay · 17 with a transcript · latest Aug 5, 2026
- Decks
- 36 decks · latest Aug 5, 2026
Where Sarepta Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SRPT · Home listing | NASDAQ | United States | USD |
| B3:S1RP34 | B3 | Brazil | BRL |
| gettex:AB3A | gettex | Germany | EUR |
| LS Exchange:A1J1BH | LS Exchange | Germany | EUR |
| Tradegate:AB3A | Tradegate | Germany | EUR |
| BMV:SRPT | BMV | Mexico | MXN |
| Lang & Schwarz:A1J1BH | Lang & Schwarz | Germany | EUR |
| LSE:0L35 | LSE | United Kingdom | USD |
| Frankfurt:AB3A | Frankfurt | Germany | EUR |
| BOATS:SRPT | BOATS | United States | USD |
| Milan:1SRPT | Milan | Italy | EUR |
| BIVA:SRPT · This page | BIVA | Mexico | MXN |
| Dusseldorf:AB3A | Dusseldorf | Germany | EUR |
| Hamburg:AB3A | Hamburg | Germany | EUR |
| Munich:AB3A | Munich | Germany | EUR |
| Stuttgart:AB3A | Stuttgart | Germany | EUR |
| BX Swiss:AB3A | BX Swiss | Switzerland | CHF |
Log in to ask 6ix AI your own questions about Sarepta Therapeutics, Inc.